Dr. Paul Donnelly, from The University of Melbourne in Australia, is conducting research to develop molecular agents that can be used in the diagnosis and treatment of Alzheimer’s. In a conference organized by the MGH Gordon Center, Dr. Donnelly presented his effort to synthesize copper and technetium complexes that can bind Aβ plaques associated with […]